Literature DB >> 19333953

High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups.

Bahram Namjou1, Andrea L Sestak, Don L Armstrong, Raphael Zidovetzki, Jennifer A Kelly, Noam Jacob, Voicu Ciobanu, Kenneth M Kaufman, Joshua O Ojwang, Julie Ziegler, Francesco P Quismorio, Andreas Reiff, Barry L Myones, Joel M Guthridge, Swapan K Nath, Gail R Bruner, Ruth Mehrian-Shai, Earl Silverman, Marisa Klein-Gitelman, Deborah McCurdy, Linda Wagner-Weiner, James J Nocton, Chaim Putterman, Sang-Cheol Bae, Yun Jung Kim, Michelle Petri, John D Reveille, Timothy J Vyse, Gary S Gilkeson, Diane L Kamen, Marta E Alarcón-Riquelme, Patrick M Gaffney, Kathy L Moser, Joan T Merrill, R Hal Scofield, Judith A James, Carl D Langefeld, John B Harley, Chaim O Jacob.   

Abstract

OBJECTIVE: Systemic lupus erythematosus (SLE) is the prototypical systemic autoimmune disorder, with complex etiology and a strong genetic component. Recently, gene products involved in the interferon pathway have been under intense investigation in terms of the pathogenesis of SLE. STAT-1 and STAT-4 are transcription factors that play key roles in the interferon and Th1 signaling pathways, making them attractive candidates for involvement in SLE susceptibility.
METHODS: Fifty-six single-nucleotide polymorphisms (SNPs) across STAT1 and STAT4 on chromosome 2 were genotyped using the Illumina platform, as part of an extensive association study in a large collection of 9,923 lupus patients and control subjects from different racial groups. DNA samples were obtained from the peripheral blood of patients with SLE and control subjects. Principal components analyses and population-based case-control association analyses were performed, and the P values, false discovery rate q values, and odds ratios with 95% confidence intervals were calculated.
RESULTS: We observed strong genetic associations with SLE and multiple SNPs located within STAT4 in different ethnic groups (Fisher's combined P = 7.02 x 10(-25)). In addition to strongly confirming the previously reported association in the third intronic region of this gene, we identified additional haplotypic association across STAT4 and, in particular, a common risk haplotype that is found in multiple racial groups. In contrast, only a relatively weak suggestive association was observed with STAT1, probably due to its proximity to STAT4.
CONCLUSION: Our findings indicate that STAT4 is likely to be a crucial component in SLE pathogenesis in multiple racial groups. Knowledge of the functional effects of this association, when they are revealed, might improve our understanding of the disease and provide new therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19333953      PMCID: PMC2776081          DOI: 10.1002/art.24387

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  49 in total

1.  The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cells.

Authors:  Wei Wang; Norma S Ostlie; Bianca M Conti-Fine; Monica Milani
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

Review 2.  Induction of clinical autoimmune disease by therapeutic interferon-alpha.

Authors:  Carmen Gota; Leonard Calabrese
Journal:  Autoimmunity       Date:  2003-12       Impact factor: 2.815

3.  Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis.

Authors:  Ram Raj Singh; Vijay Saxena; Song Zang; Lily Li; Fred D Finkelman; David P Witte; Chaim O Jacob
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

Review 4.  The emerging role of interferon in human systemic lupus erythematosus.

Authors:  Emily C Baechler; Peter K Gregersen; Timothy W Behrens
Journal:  Curr Opin Immunol       Date:  2004-12       Impact factor: 7.486

5.  Signal transducer and activator of transcription (Stat)-6-dependent, but not Stat4-dependent, immunity is required for the development of autoimmunity in Graves' hyperthyroidism.

Authors:  Kimberly J Land; Jennifer S Moll; Mark H Kaplan; Gattadahalli S Seetharamaiah
Journal:  Endocrinology       Date:  2004-04-29       Impact factor: 4.736

6.  Systemic lupus erythematosus genome scan: support for linkage at 1q23, 2q33, 16q12-13, and 17q21-23 and novel evidence at 3p24, 10q23-24, 13q32, and 18q22-23.

Authors:  Rita M Cantor; Jinying Yuan; Susan Napier; Naoko Kono; Jennifer M Grossman; Bevra H Hahn; Betty P Tsao
Journal:  Arthritis Rheum       Date:  2004-10

7.  Pivotal role of Stat4 and Stat6 in the pathogenesis of the lupus-like disease in the New Zealand mixed 2328 mice.

Authors:  Chaim O Jacob; Song Zang; Lily Li; Voicu Ciobanu; Frank Quismorio; Akiei Mizutani; Minoru Satoh; Michael Koss
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

8.  Autoimmune diabetes is blocked in Stat4-deficient mice.

Authors:  Zandong Yang; Meng Chen; Justin D Ellett; Lawrence B Fialkow; Jeffrey D Carter; Marcia McDuffie; Jerry L Nadler
Journal:  J Autoimmun       Date:  2004-05       Impact factor: 7.094

Review 9.  Microarray analysis of interferon-regulated genes in SLE.

Authors:  Mary K Crow; Kyriakos A Kirou; Jay Wohlgemuth
Journal:  Autoimmunity       Date:  2003-12       Impact factor: 2.815

10.  In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon.

Authors:  C O Jacob; P H van der Meide; H O McDevitt
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

View more
  36 in total

Review 1.  Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways.

Authors:  Samuel E Vaughn; Leah C Kottyan; Melissa E Munroe; John B Harley
Journal:  J Leukoc Biol       Date:  2012-06-29       Impact factor: 4.962

Review 2.  Recent insights into the genetic basis of systemic lupus erythematosus.

Authors:  K L Moser; J A Kelly; C J Lessard; J B Harley
Journal:  Genes Immun       Date:  2009-05-14       Impact factor: 2.676

Review 3.  Exploring the etiopathogenesis of systemic lupus erythematosus: a genetic perspective.

Authors:  Ali Javinani; Amir Ashraf-Ganjouei; Saeed Aslani; Ahmadreza Jamshidi; Mahdi Mahmoudi
Journal:  Immunogenetics       Date:  2019-01-22       Impact factor: 2.846

Review 4.  Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.

Authors:  Chandra Mohan; Chaim Putterman
Journal:  Nat Rev Nephrol       Date:  2015-03-31       Impact factor: 28.314

5.  A cross-ethnic survey of CFB and SLC44A4, Indian ulcerative colitis GWAS hits, underscores their potential role in disease susceptibility.

Authors:  Aditi Gupta; Garima Juyal; Ajit Sood; Vandana Midha; Keiko Yamazaki; Arnau Vich Vila; Motohiro Esaki; Toshiyuki Matsui; Atsushi Takahashi; Michiaki Kubo; Rinse K Weersma; B K Thelma
Journal:  Eur J Hum Genet       Date:  2016-10-19       Impact factor: 4.246

Review 6.  Genetics of Lupus Nephritis: Clinical Implications.

Authors:  Melissa E Munroe; Judith A James
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

Review 7.  Genetics of rheumatic disease.

Authors:  Alex Clarke; Timothy J Vyse
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

Review 8.  Genetic associations in type I interferon related pathways with autoimmunity.

Authors:  Angélica M Delgado-Vega; Marta E Alarcón-Riquelme; Sergey V Kozyrev
Journal:  Arthritis Res Ther       Date:  2010-04-14       Impact factor: 5.156

Review 9.  Clinical perspectives on lupus genetics: advances and opportunities.

Authors:  Judith A James
Journal:  Rheum Dis Clin North Am       Date:  2014-06-10       Impact factor: 2.670

10.  Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology.

Authors:  Hideaki Tahara; Marimo Sato; Magdalena Thurin; Ena Wang; Lisa H Butterfield; Mary L Disis; Bernard A Fox; Peter P Lee; Samir N Khleif; Jon M Wigginton; Stefan Ambs; Yasunori Akutsu; Damien Chaussabel; Yuichiro Doki; Oleg Eremin; Wolf Hervé Fridman; Yoshihiko Hirohashi; Kohzoh Imai; James Jacobson; Masahisa Jinushi; Akira Kanamoto; Mohammed Kashani-Sabet; Kazunori Kato; Yutaka Kawakami; John M Kirkwood; Thomas O Kleen; Paul V Lehmann; Lance Liotta; Michael T Lotze; Michele Maio; Anatoli Malyguine; Giuseppe Masucci; Hisahiro Matsubara; Shawmarie Mayrand-Chung; Kiminori Nakamura; Hiroyoshi Nishikawa; A Karolina Palucka; Emanuel F Petricoin; Zoltan Pos; Antoni Ribas; Licia Rivoltini; Noriyuki Sato; Hiroshi Shiku; Craig L Slingluff; Howard Streicher; David F Stroncek; Hiroya Takeuchi; Minoru Toyota; Hisashi Wada; Xifeng Wu; Julia Wulfkuhle; Tomonori Yaguchi; Benjamin Zeskind; Yingdong Zhao; Mai-Britt Zocca; Francesco M Marincola
Journal:  J Transl Med       Date:  2009-06-17       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.